Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Critics say Canada’s new immigration and border law puts LGBTQ+ people in danger

June 13, 2026

Microsoft hasn’t ruled out spinning off Xbox

June 13, 2026

Bose’s latest QuietComfort Ultra are $70 off, marking a new low price 

June 13, 2026

My first 24 hours with Siri AI on the Mac

June 13, 2026

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zscaler

June 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Drug Eluting Balloon Market Forecast: Significant Growth Predicted in Coronary and Peripheral DEBs by 2030
Press Release

Drug Eluting Balloon Market Forecast: Significant Growth Predicted in Coronary and Peripheral DEBs by 2030

By News RoomJanuary 5, 20242 Mins Read
Drug Eluting Balloon Market Forecast: Significant Growth Predicted in Coronary and Peripheral DEBs by 2030
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) — The “Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The latest market analysis on the Drug Eluting Balloon (DEB) sector reveals a robust expansion trajectory, with an estimated compound annual growth rate (CAGR) of 15.21% from 2023 to 2030. Advanced insights into this burgeoning market indicate that by the end of the forecast period, it will have reached a valuation of USD 2,650.47 million, driven predominantly by developments in Coronary and Peripheral DEBs.

Within the array of Drug Eluting Balloons, differing types are analyzed, including Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon, with the former holding the majority market share in the recent year. Detailed examination of the subsets of these balloons, such as Coronary and Peripheral DCB, further enriches the market understanding.

An expansive section of the study is dedicated to end-users, including Ambulatory Surgery Centers, Cath Labs, and Hospitals, with Hospitals commanding a significant majority of the market in the preceding year.

Regional analysis encompasses a comprehensive view across the Americas, Asia-Pacific, and Europe, Middle East & Africa, with the Europe, Middle East & Africa region reported to hold the prevailing market share recently, succeeded by the Americas.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Cook Medical, Inc.
  • Eurocor Tech GmbH
  • iVascular S.L.U.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Laborie Medical Technologies, Inc.
  • M.A. Med Alliance SA
  • Medtronic PLC
  • SurModics, Inc.
  • Terumo Corporation

The report’s advanced analytics answer crucial market-derived questions, enabling decision-makers to chart proficient market entry and expansion strategies. Insights into the latest technology trends and regulatory frameworks provide stakeholders with an edge in the rapidly evolving Drug Eluting Balloon Market landscape.

For more information about this report visit https://www.researchandmarkets.com/r/nojc2o

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Drug Eluting Balloon Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zscaler

BTGO EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

FemiCore (Official Website & Authenticity Notice 2026) – Counterfeit Risks and What Consumers Should Know

BMI EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Badger Meter (BMI) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Hyderabad Sees Surge in Dining Table Rentals in 2026 as Salaried IT Professionals Reject ₹45,000 EMI Lock-Ins for ₹1,400/Month Plans From Rentomojo

PHR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

RBLX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Notifies Roblox (RBLX) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

Don’t Pay Full Price for Power: WattCycle’s Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15

AVAV EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds AeroVironment (AVAV) Investors of Securities Class Action Lawsuit Deadline on July 27, 2026

Editors Picks

Microsoft hasn’t ruled out spinning off Xbox

June 13, 2026

Bose’s latest QuietComfort Ultra are $70 off, marking a new low price 

June 13, 2026

My first 24 hours with Siri AI on the Mac

June 13, 2026

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zscaler

June 13, 2026

Latest News

Never Post’s Mike Rugnetta on the creative process and the value of reliable power

June 13, 2026

BTGO EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

June 13, 2026

FemiCore (Official Website & Authenticity Notice 2026) – Counterfeit Risks and What Consumers Should Know

June 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version